Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
73.60Prev. Close
73.60Volume
7,579Total traded value
0.06 CrUpper Circuit
88.32Lower Circuit
58.88Fundamentals
| Market Cap | ₹361Cr |
| ROE | 2.62% |
| P/E Ratio(TTM) | 54.94 |
| EPS(TTM) | 1.35 |
| P/B Ratio | 1.44 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.27 |
| Book Value | 51.57 |
| Debt to Equity | 0.48 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Zim Laboratories Limited.
ZIM Laboratories is a research-driven Indian pharmaceutical company that provides innovative Drug Delivery Solutions like complex generics and Oral Thin Films (OTF) globally. Its vision is to make quality healthcare affordable by developing drug delivery methods that are focused on patient convenience and treatment adherence. The company's revenue from its New Innovative Products (NIP) and Oral Thin Films (OTF) grew by 65% year-on-year in FY25.;
| Parent Organisation | Zim Laboratories Limited. |
| Managing Director | Dr. Anwar Daud |
| NSE Symbol | ZIMLAB |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.21 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.69 | ||
| Cohance Lifesciences | NA (0.00%) | 71.09 | ||
| Wockhardt | NA (0.00%) | -423.74 |